Page 6 - Research Models News Today

Van ECK Associates Corp trimmed its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 8.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 57,679 shares of the medical research company’s stock after selling 5,418 shares during […]

Van ECK Associates Corp lessened its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 8.6% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 57,679 shares of the medical research company’s stock after selling 5,418 shares during the period. Van ECK Associates […]

Investment House LLC lowered its stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 1.0% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 68,126 shares of the medical research company’s stock after selling 706 shares during the quarter. Charles […]

Valmark Advisers Inc. bought a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 3,000 shares of the medical research company’s stock, valued at approximately $709,000. Other hedge funds […]

New York State Common Retirement Fund reduced its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 4.1% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 131,078 shares of the medical research company’s stock after selling 5,565 shares during the […]

New York State Common Retirement Fund trimmed its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 4.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 131,078 shares of the medical research company’s stock after selling 5,565 […]

CNB Bank boosted its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 9.7% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 2,962 shares of the medical research company’s stock after purchasing an additional 263 shares during the period. CNB Bank’s holdings in Charles […]

Shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the eleven ratings firms that are currently covering the stock, Marketbeat Ratings reports. Four analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The […]

Inotiv (NASDAQ:NOTV – Get Free Report) and OneMedNet (NASDAQ:ONMD – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, earnings, profitability, institutional ownership, dividends and valuation. Risk and Volatility Inotiv has a beta of 3.16, […]

Sequoia Financial Advisors LLC boosted its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 1,256.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 14,108 shares of the medical research company’s stock after purchasing an additional 13,068 shares […]